BIOS

BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS

Overview Fund Activity
Delisted

BIOS was delisted on the 6th of October, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 30 closing their positions.

Holders
–
Holders Change
-30
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
WCMNY
1
Westchester Capital Management (New York)
New York
$0
2
WRBC
2
W.R. Berkley Corp
Connecticut
$0
3
FTCM
3
First Trust Capital Management
Illinois
$0
4
LA
4
Linden Advisors
New York
$0
5
RCM
5
Radcliffe Capital Management
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
ETH
26
Exos TFP Holdings
New York
– – -60,000 Closed
AMC
27
Atlas Merchant Capital
New York
– – -50,000 Closed
VF
28
Virtu Financial
New York
– – -20,445 Closed
KIM
29
Karpus Investment Management
New York
– – -10,235 Closed
CS
30
Clear Street
New York
– – -1 Closed
PP
31
Paloma Partners
Connecticut
– – – –
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
1
2